This requirement is for reagents and service support plans.
Ended Awarded Last action
- Contract number
- HT942524F0217
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $668,202
Award facts
- Contract value 100% obligated
- $668,201.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Takoma Park, MD 20901, USA
Award details come from SAM.gov/FPDS.
About this award
Illumina, Inc. has been awarded a Blanket Purchase Agreement (BPA) call valued at $668,201.76 by the Defense Health Agency for the provision of reagents and service support plans. The award, executed on September 12, 2024, is structured as a firm fixed price contract with an ultimate completion date of September 30, 2025. Work will be performed at the contractor's facility in Takoma Park, Maryland. The contract was awarded without set-aside designation, reflecting Illumina's specialized technological capabilities in genomic sequencing and reagent provision. As a leading biotechnology company headquartered in San Diego, California, Illumina manufactures advanced DNA and RNA sequencing instruments, reagents, consumables, and bioinformatics software that serve multiple federal agencies across both civilian and defense sectors.
This BPA call falls under Illumina's broader engagement with the Department of Defense and its subordinate agencies, supporting critical healthcare diagnostics and scientific research initiatives. The Defense Health Agency's procurement of reagents and service support plans aligns with federal military medicine's ongoing requirements for advanced genomic analysis capabilities to support clinical diagnostics, research, and healthcare operations. Illumina's consistent contract performance across federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Agriculture, and the Department of Veterans Affairs demonstrates the company's established position as a primary supplier of genomic sequencing technologies and associated consumables to the federal government.
Quick answers
Who was awarded contract HT942524F0217?
HT942524F0217 was awarded to Illumina, Inc. by Defense Health Agency (Department of Defense) on September 12, 2024.
How much is contract HT942524F0217 worth?
The government has obligated $668,202 on HT942524F0217.
Is contract HT942524F0217 an order under another contract?
Yes. HT942524F0217 is a BPA call under W81XWH20A0007, a blanket purchase agreement.
Was contract HT942524F0217 competed?
The extent of competition for HT942524F0217 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award